Telomere length of blood-derived mononuclear cells from cancer patients during G-CSF-enhanced marrow recovery.
Kronenwett
R
R
Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center, Heidelberg, Germany.
Murea
S
S
Haas
R
R
D000328:Adult; D018952:Antigens, CD34 / Q000097:blood; D001483:Base Sequence; D004273:DNA, Neoplasm / Q000235:genetics; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D006801:Humans; D007937:Leukapheresis; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000235:genetics* / Q000628:therapy*; D012091:Repetitive Sequences, Nucleic Acid; D016615:Telomere / Q000235:genetics*
D018952:Antigens, CD34; D004273:DNA, Neoplasm; D016179:Granulocyte Colony-Stimulating Factor